Achaogen Company Profile (NASDAQ:AKAO)

About Achaogen

Achaogen logoAchaogen, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterials to treat multi-drug resistant (MDR) gram-negative infections. The Company is developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant enterobacteriaceae (CRE). Plazomicin is an aminoglycoside designed to overcome clinically relevant aminoglycoside resistance mechanisms. In addition, its research and development pipeline includes two programs that specifically target Pseudomonas aeruginosa or Acinetobacter baumannii infections: a program to discover and develop small molecule inhibitors of LpxC, which is an enzyme essential for the synthesis of the outer membrane of gram-negative bacteria, and a therapeutic antibody program. Its development plan for plazomicin includes over two Phase III clinical trials.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AKAO
  • CUSIP:
Key Metrics:
  • Previous Close: $5.21
  • 50 Day Moving Average: $4.66
  • 200 Day Moving Average: $3.89
  • 52-Week Range: $26,679,000.00 - $2.59
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.64
  • P/E Growth: 0.00
  • Market Cap: $146.47M
  • Outstanding Shares: 26,679,000
  • Beta: 0.51
  • Net Margins: -209.23%
  • Return on Equity: -118.45%
  • Return on Assets: -68.85%
  • Debt-to-Equity Ratio: 0.66%
  • Current Ratio: 5.19%
  • Quick Ratio: 5.19%
Additional Links:
Companies Related to Achaogen:

Analyst Ratings

Consensus Ratings for Achaogen (NASDAQ:AKAO) (?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $10.00 (82.15% upside)

Analysts' Ratings History for Achaogen (NASDAQ:AKAO)
DateFirmActionRatingPrice TargetDetails
9/27/2016WedbushReiterated RatingOutperform$10.00View Rating Details
9/26/2016SunTrust Banks Inc.Reiterated RatingBuy$10.00View Rating Details
8/9/2016Needham & Company LLCReiterated RatingHoldView Rating Details
3/31/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details
8/10/2015Cantor FitzgeraldReiterated RatingBuy$13.00View Rating Details
3/2/2015Credit Suisse Group AGDowngradeOutperform -> Underperform$22.00 -> $13.00View Rating Details
10/30/2014Canaccord GenuityInitiated CoverageBuy$13.00View Rating Details
(Data available from 10/23/2014 forward)


Earnings History for Achaogen (NASDAQ:AKAO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q2($0.67)($0.87)$5.58 million$9.14 millionViewN/AView Earnings Details
3/15/2016Q414($0.58)($0.61)$5.33 million$4.70 millionViewListenView Earnings Details
11/5/2015($0.45)($0.48)ViewN/AView Earnings Details
8/10/2015($0.20)($0.05)ViewN/AView Earnings Details
5/11/2015($0.26)($0.34)ViewN/AView Earnings Details
3/16/2015($0.33)($0.27)ViewN/AView Earnings Details
11/10/2014Q314($0.25)($0.47)$6.00 million$4.52 millionViewN/AView Earnings Details
8/11/2014($0.19)($0.20)ViewN/AView Earnings Details
5/12/2014Q114($0.48)($1.00)$5.39 million$6.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Achaogen (NASDAQ:AKAO)
Current Year EPS Consensus Estimate: $-2.64 EPS
Next Year EPS Consensus Estimate: $-2.08 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.71)($0.52)($0.62)
Q2 20164($0.71)($0.52)($0.62)
Q3 20163($0.53)($0.33)($0.43)
Q4 20163($0.63)($0.41)($0.48)
Q1 20171($0.56)($0.56)($0.56)
Q2 20171($0.67)($0.67)($0.67)
Q3 20171($0.72)($0.72)($0.72)
Q4 20171($0.67)($0.67)($0.67)
(Data provided by Zacks Investment Research)


Dividend History for Achaogen (NASDAQ:AKAO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Achaogen (NASDAQ:AKAO)
Insider Ownership Percentage: 13.80%
Institutional Ownership Percentage: 56.84%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/27/2016Blake WiseCOOSell3,632$4.30$15,617.60View SEC Filing  
9/27/2016Zeryn SarpangalVPSell1,069$4.30$4,596.70View SEC Filing  
3/17/2016Ian FriedlandInsiderSell1,772$3.22$5,705.84View SEC Filing  
3/17/2016Kenneth J HillanCEOSell3,572$3.22$11,501.84View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Achaogen (NASDAQ:AKAO)
News IconAre Achaogen, Inc. (NASDAQ:AKAO) Shares Heading Higher? - Recall News (NASDAQ:AKAO) - October 17 at 3:24 PM
News IconStock Scrambling Higher Mid-session: Achaogen, Inc. (NASDAQ:AKAO) - CSZ News (NASDAQ:AKAO) - October 17 at 3:24 PM
News IconForging Higher Over Past 6-Months, Can It Continue For Achaogen, Inc. (NASDAQ:AKAO) - CSZ News (NASDAQ:AKAO) - October 16 at 3:23 PM
News IconVersant Venture Management LLC Holds Position in Achaogen Inc. (AKAO) - DailyQuint (NASDAQ:AKAO) - October 15 at 3:21 PM
News IconIs This Equity Ready for a Breakout: Achaogen, Inc. (NASDAQ:AKAO) - Yankee Analysts (NASDAQ:AKAO) - October 14 at 3:23 PM
News IconLooking Ahead for Achaogen, Inc. (NASDAQ:AKAO); Are These Shares Ready to Go Higher? - CSZ News (NASDAQ:AKAO) - October 13 at 3:23 PM
News IconStock Propelling Higher as it is Gapping up: Achaogen, Inc. (NASDAQ:AKAO) - Recall News (NASDAQ:AKAO) - October 11 at 8:29 PM logoETF’s with exposure to Achaogen, Inc. : October 7, 2016 (NASDAQ:AKAO) - October 7 at 3:24 PM
News IconShort Interest Coverage: Achaogen Incorporated (NASDAQ:AKAO) Sellers Increased By 1.22% Their Shorts - Post News (NASDAQ:AKAO) - October 6 at 9:09 AM
News IconLatest Analyst Ratings For Achaogen, Inc. (AKAO) - The De Soto Edge (NASDAQ:AKAO) - October 3 at 8:11 AM
News IconAchaogen Inc(NASDAQ:AKAO): That’s How Our members At Traders Insights Made Quick 25% In 3- Week (NASDAQ:AKAO) - October 1 at 8:51 AM
News IconAchaogen Inc(NASDAQ:AKAO): That's How Our members At Traders Insights Made Quick 25% In 3- Week - Market News Call (NASDAQ:AKAO) - September 30 at 3:52 PM logoSunTrust Reiterates Buy On Achaogen, Sees Plazomicin As An 'Undervalued Asset' (NASDAQ:AKAO) - September 26 at 8:24 PM logoShares Of Achaogen, Inc. (NASDAQ:AKAO) Expected To Hit $11 - Investor Newswire (NASDAQ:AKAO) - September 25 at 8:10 AM
News IconAchaogen Incorporated (NASDAQ:AKAO) Short Interest Decreased By 9.87% - Frisco Fastball (NASDAQ:AKAO) - September 14 at 3:25 PM logoStocks Swings: Achaogen, Inc. (NASDAQ:AKAO), Hilton Worldwide Holdings Inc. (NYSE:HLT), The TJX Companies ... - KC Register (NASDAQ:AKAO) - September 12 at 3:24 PM
News IconPlacing Achaogen, Inc. (NASDAQ:AKAO) Shares Under the Microscope - Post News (NASDAQ:AKAO) - September 9 at 8:11 AM
News IconShares Higher in Today's Session: Achaogen, Inc. (NASDAQ:AKAO) - Post News (NASDAQ:AKAO) - September 8 at 3:23 PM
News IconWhat are Research Firms Saying About Achaogen, Inc. (NASDAQ:AKAO)? - Frisco Fastball (NASDAQ:AKAO) - September 7 at 8:32 PM logoTop 20 Most Advanced Stocks on NASDAQ, Sept. 6 (NASDAQ:AKAO) - September 6 at 8:11 AM
News IconNext Weeks Broker Price Targets For Itron, Inc. (NASDAQ:ITRI) (NASDAQ:AKAO) - September 6 at 8:11 AM
News IconList: Itron, Inc. (NASDAQ:ITRI) , Achaogen, Inc. (NASDAQ:AKAO) (NASDAQ:AKAO) - September 6 at 8:11 AM
News IconAnalyst Watch-list: Itron, Inc. (NASDAQ:ITRI) , Achaogen, Inc. (NASDAQ:AKAO) - Wall Street Times (press release) (NASDAQ:AKAO) - September 2 at 3:26 PM logoACHAOGEN INC Files SEC form 8-K, Other Events (NASDAQ:AKAO) - September 2 at 8:02 AM logoAchaogen (AKAO) Says Phase 3 EPIC Trial Enrollment Complete - (NASDAQ:AKAO) - September 1 at 11:51 AM logoAchaogen Completes Patient Enrollment in Phase 3 EPIC Clinical Trial of Plazomicin (NASDAQ:AKAO) - September 1 at 11:51 AM logoAchaogen Announces New Employment Inducement Grants (NASDAQ:AKAO) - August 22 at 8:12 AM logoWill Achaogen, Inc. (NASDAQ:AKAO) Hit $11 Price Target? - Investor Newswire (NASDAQ:AKAO) - August 21 at 8:11 AM logoACHAOGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:AKAO) - August 18 at 8:53 PM logoACHAOGEN INC Financials (NASDAQ:AKAO) - August 16 at 3:25 PM logoAchaogen to Present at the Wedbush PacGrow Healthcare Conference - GlobeNewswire (press release) (NASDAQ:AKAO) - August 10 at 3:45 PM logoAchaogen to Present at the Wedbush PacGrow Healthcare Conference (NASDAQ:AKAO) - August 10 at 11:14 AM logoAchaogen Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:AKAO) - August 8 at 8:52 PM logoAchaogen Inc.: Achaogen Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:AKAO) - August 8 at 8:52 PM logoAchaogen reports 2Q loss (NASDAQ:AKAO) - August 8 at 8:52 PM logoAchaogen Inc. (AKAO) Drops 7.12% on August 01 - (NASDAQ:AKAO) - August 3 at 11:58 AM logoAchaogen, Inc. (AKAO) Updated Price Targets - FTSE News (NASDAQ:AKAO) - August 1 at 8:12 AM logoIs $12 Price Target Attainable For Achaogen, Inc. (NASDAQ:AKAO)? - Investor Newswire (NASDAQ:AKAO) - July 24 at 8:10 AM
News IconStock Up Nicely This Week: Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO) - July 23 at 3:24 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO) - July 22 at 11:36 AM logoBroker Outlook For Achaogen, Inc. (AKAO) - Fiscal Standard (NASDAQ:AKAO) - July 21 at 8:58 PM
News IconAchaogen Inc Increases Again; Strong Momentum for Buyers - Press Telegraph (NASDAQ:AKAO) - July 21 at 3:24 PM
News IconAchaogen Inc's Trend Up, Especially After Today's Strong Session - Consumer Eagle (NASDAQ:AKAO) - July 21 at 3:24 PM
News IconIs Achaogen Inc's Fuel Running Low? The Stock Just Declined Again - Consumer Eagle (NASDAQ:AKAO) - July 20 at 10:51 PM
News IconIncreased Stock Volatility Watch: Achaogen, Inc. (NASDAQ:AKAO) - Engelwood Daily (NASDAQ:AKAO) - July 20 at 10:51 PM
News IconShares Jumping Higher in Session: Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO) - July 20 at 10:51 PM logoAchaogen Inc. (AKAO) Jumps 9.63% on July 20 - (NASDAQ:AKAO) - July 20 at 10:51 PM logoAchaogen Inc : LifeSci Capital Initiates Coverage of Achaogen (NASDAQ:AKAO) - July 20 at 4:29 PM
News IconAchaogen Incorporated (NASDAQ:AKAO) Sellers Increased By 30.9% Their Shorts - Consumer Eagle (NASDAQ:AKAO) - July 19 at 8:51 PM logoLifeSci Capital Initiates Coverage of Achaogen (NASDAQ:AKAO) - July 19 at 1:45 PM


Achaogen (NASDAQ:AKAO) Chart for Sunday, October, 23, 2016

Last Updated on 10/23/2016 by Staff